What is the most likely cause of short stature in a 13‑year‑old boy with height 140 cm, weight 39 kg, bone age 10 years, Tanner stage I, parental heights of 165 cm (mother) and 178 cm (father), and no chronic illness?

Constitutional Delay of Growth and Puberty (CDGP)

This 13-year-old boy's short stature is most likely caused by constitutional delay of growth and puberty (CDGP), a benign variant of normal growth characterized by delayed bone age, prepubertal status at an age when puberty would typically be underway, and eventual attainment of normal adult height.

Clinical Reasoning

The diagnosis of CDGP is strongly supported by the following key features 1:

• Delayed bone age: His bone age of 10 years represents a 3-year delay compared to his chronological age of 13 years, which is the hallmark finding in CDGP
• Prepubertal status: Tanner stage I at age 13 indicates delayed pubertal development, consistent with CDGP
• Growth pattern: The deceleration in linear growth during early childhood followed by tracking along a lower percentile is characteristic of CDGP 1
• Normal growth velocity: His growth chart shows he is maintaining his growth curve without crossing multiple percentile lines downward after age 3, suggesting normal childhood growth velocity (4-7 cm/year expected) 1
• Appropriate target height: With parental heights of 165 cm (mother) and 178 cm (father), his mid-parental target height is approximately 165 cm for a male, which is achievable given his delayed bone age provides additional growth potential

Distinguishing CDGP from Pathologic Causes

Why not pathologic short stature?

The examination is described as "unremarkable" with no dysmorphic features, developmental delays, or disproportionate body habitus, effectively ruling out:

• Skeletal dysplasias (would show disproportionate measurements) 1
• Syndromic causes like Turner syndrome (male patient, no associated anomalies) 1
• Chronic systemic disease (healthy, active in sports)
• Primary endocrinopathies (would typically show more severe growth deceleration and crossing of percentile lines) 1

Why not familial short stature (FSS)?

FSS is characterized by normal bone age and normal pubertal timing 1. This patient has significantly delayed bone age (3 years) and delayed puberty, excluding pure FSS. However, there may be an overlapping component given his parents' heights are in the lower-normal range.

Why not growth hormone deficiency (GHD)?

GHD typically presents with:

• More severe height deficit
• Crossing of multiple growth percentiles after age 3
• Bone age delay often exceeding 2 years (though this patient has 3-year delay)
• Often associated with other pituitary hormone deficiencies 1

While his 3-year bone age delay could raise suspicion for GHD, the maintenance of his growth curve without progressive deceleration and his otherwise normal examination make CDGP more likely. If concern persists, IGF-1 and IGFBP-3 levels with possible GH stimulation testing could be considered 2.

Expected Natural History

Reassurance is key: Children with CDGP typically experience:

• Continued normal growth velocity during childhood (4-7 cm/year) 1
• Delayed but eventually normal pubertal development
• Pubertal growth spurt occurring later than peers
• Final adult height within the normal range and appropriate for target height 1

The delayed bone age of 10 years indicates he has approximately 3 additional years of growth potential compared to his chronological age, which will allow catch-up growth during his delayed but eventually normal puberty 3.

Clinical Pitfalls to Avoid

1. Over-investigation: Extensive endocrine workup is not warranted when the clinical picture clearly suggests CDGP. The bone age delay and prepubertal status at age 13 are sufficient 1

2. Premature GH therapy: CDGP is a normal variant, not a disease requiring treatment. Studies show that bone age delay is the key predictor of spontaneous catch-up growth, particularly after pubertal onset 3

3. Missing pathology: If growth velocity were abnormal (crossing percentile lines downward) or if there were any dysmorphic features, systemic symptoms, or disproportionate measurements, further evaluation would be mandatory 1

4. Family history: Careful questioning about parental growth patterns and pubertal timing often reveals a family history of late puberty, supporting the diagnosis 1

Management Approach

• Longitudinal monitoring: Serial height measurements every 4-6 months to confirm normal growth velocity 1
• Reassurance: Educate the patient and family about the benign nature and expected outcomes
• Psychosocial support: Address concerns about being the shortest in class; consider psychological impact of delayed puberty
• Re-evaluation triggers: If growth velocity falls below 4 cm/year or if puberty has not initiated by bone age 13-14 years, reconsider the diagnosis 1

The combination of delayed bone age, prepubertal status at age 13, normal growth velocity, and unremarkable examination makes CDGP the most likely diagnosis, with excellent prognosis for normal adult height 1, 3.